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Protocol
AbstrACt
Introduction For patients with advanced cancer, timely 
access to palliative care can improve quality of life and 
enable patients to participate in decisions about their 
end-of-life care. However, in a UK population of 2500 
patients who died from cancer, one-third did not receive 
specialist palliative care, and of those who did, the 
duration of involvement was too short to maximise the 
benefits. Initiating a conversation about palliative care is 
challenging for some health professionals and patients 
often have unmet information needs and misconceptions 
about palliative care. We will work closely with patients 
and health professionals to develop a patient decision 
aid and health professional training module designed 
to facilitate a timely and informed conversation about 
palliative care.
Methods and analysis This study is being conducted 
over 24 months from November 2017 to October 
2019 and follows the UK Medical Research Council 
framework for developing complex interventions and the 
International Patient Decision Aids Guideline. The Ottawa 
Decision Support Framework underpins the study. The 
Supporting Timely Engagement with Palliative care (STEP) 
intervention will be developed though an iterative process 
informed by interviews and focus groups with patients 
with advanced cancer, oncologists, general practitioners 
and palliative care doctors. An expert panel will also 
review each iteration. The expert panel will consist of 
a patient representative with experience of palliative 
care, health professionals who are involved in advanced 
cancer care decision-making, a medical education expert 
and the National Council for Palliative Care director of 
transformation. The feasibility and acceptability of the 
decision aid and doctor training will be tested in oncology 
and general practice settings.
Ethics and dissemination Ethical approval for the 
study has been granted by the Office for Research Ethics 
Committees Northern Ireland (ORECNI), approval reference 
17/NI/0249. Dissemination and knowledge transfer will be 
conducted via publications, national bodies and networks, 
and patient and family groups.
IntroduCtIon
The aim of palliative care is to relieve 
suffering and improve the quality of life of 
patients with advanced illnesses. The value 
of timely integration of palliative care was 
acknowledged over 15 years ago when WHO 
incorporated the phrase ‘relief of suffering 
by means of early identification and impeccable 
assessment’ within its 2002 definition of palli-
ative care. For patients with advanced cancer, 
several randomised controlled trials1–5 have 
strengths and limitations of this study
 ► To the best of our knowledge, this is the first study 
to develop a patient decision aid and health profes-
sional training module designed to facilitate a timely 
and informed conversation about referral to pallia-
tive care.
 ► Evidence synthesis and close collaboration with 
patients and health professionals will enable us to 
iteratively develop an intervention that overcomes 
existing barriers to integration of palliative care 
within cancer services.
 ► The research will follow the UK MRC framework 
for developing complex interventions and the 
International Patient Decision Aids guideline, and 
be underpinned by the Ottawa Decision Support 
Framework.
 ► The research will provide evidence of its acceptabil-
ity and feasibility to patients and healthcare profes-
sionals within routine care in oncology outpatient 
clinics and general practitioner practices.
 ► The research will be conducted in one country, the 
UK. While directly relevant to inform policy and prac-
tice in this context, it is possible that patient and 
health professional experiences of the existing bar-
riers to integration of palliative care within cancer 
services may vary across countries.
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shown that early access to palliative care can improve 
quality of life, reduce acute hospital admissions, mini-
mise aggressive cancer treatments and enable patients 
to make choices about their end-of-life care, including 
exercising the choice to die at home. Earlier integration 
of palliative care can also improve pain control6 and help 
address inequalities in access to good-quality end-of-
life care.7 The accumulating evidence to support early 
referral is beginning to influence policy in the USA8; in 
2012, the American Society of Clinical Oncology issued 
guidance to its members recommending ‘palliative care 
should be considered early in the course of illness for 
any patient with metastatic cancer and/or high symptom 
burden’.7 9 
Previous research suggests that 3–6 months of palliative 
care is required in order to achieve high-quality end-of-
life care.1–5 8 However, the current timing of referral to 
specialist palliative care services in the UK is consider-
ably shorter than this, which is likely to limit the provi-
sion of high-quality end-of-life care.7 10 Although health 
professionals in the UK acknowledge the importance of 
timely referral,11 they recognise that in practice, referral 
does not usually occur until a patient is nearing end 
of life or experiences an acute episode.11–13 Barriers to 
referral reported by health professionals include attempts 
to delay the termination of active treatment, belief that 
they would be abandoning the patient, difficulty initi-
ating the conversation about palliative care and lack of 
expertise dealing with end-of-life issues. Patient barriers 
include misconceptions regarding the role of hospices 
and Macmillan nurses,14 15 including assumptions that 
palliative care was only for patients at the very end of 
life and a lack of appreciation of the breadth of services 
provided.16 The misconceptions reported by some studies 
suggest that palliative care should be explained in more 
detail when it is first introduced.14
Tomlinson16 identified a lack of written patient infor-
mation about the role of the specialist palliative care 
services as a barrier to timely referral. To explore the 
level of patient information material available locally, we 
undertook a survey of 12 National Health Service (NHS) 
Trusts (17 inpatient wards, 12 outpatient wards, 12 day 
units and 12 palliative care teams) across Yorkshire and 
Humber in June 2016. Only four of the Trusts surveyed 
had written information accessible to patients outside of 
palliative care. This was typically given to patients after 
they had received a referral to palliative care and focused 
on practical issues such as contact numbers for palliative 
care team rather than addressing the prevalent miscon-
ceptions about palliative care.13 Most of the palliative 
care teams had information leaflets available, but four 
specifically said that it was either out of date or that they 
preferred not to use it. There is an evident lack of under-
standing of palliative care from the patients’ perspective 
and a lack of information provision and resources to 
support decision-making. Given the barriers described 
above, we explored whether there was existing evidence 
to support the use of decision aids in this context.
Decision support tools, also known as decision aids, 
are used in a range of healthcare conditions, and have 
been defined as an intervention to help patients make 
informed choices and encourage them to consider their 
own thoughts and values.17–21 Typically, such tools have 
four components: summarising evidence-informed and 
best practice options; presenting patients and families with 
the risks and benefits of the choices available to them22 23; 
checking patients’ understanding of their options; clarify 
personal values and preferences that influence choices. 
There is evidence they can reduce patients’ uncertainty, 
increase patients’ knowledge, help create realistic expec-
tations and increase participation in decision-making.24 
Although decision aids have been shown to be effective 
in various healthcare settings,25–28 our systematic searches 
of national and international decision aid registries and 
databases identified only four decision aids, which related 
broadly to end-of-life issues such as resuscitation deci-
sions and decisions relating to preferred place of death. 
We have been unable to identify any existing decision 
aids to support decisions about palliative care referral. 
There is a clear lack of information provision in oncology 
settings and a surprising lack of existing decision aids to 
help patients make informed decisions about palliative 
care referral. The latter may be partly explained by deci-
sion aids being reliant on the provision of evidence-based 
information to support the options under consideration. 
It is only since 2011 that reliable evidence has become 
available to demonstrate the benefit of palliative care to 
patients with advanced cancer.1–5 8
The proposed project addresses an issue that is timely 
in terms of government policy,29–31 is a national clinical 
priority and has the potential to be used in other health-
care contexts across the NHS to engage non-cancer popu-
lations with palliative care. By drawing on stakeholder 
consultation, guided by the UK Medical Research Council 
framework for developing complex interventions and the 
International Patient Decision Aids Standards (IPDAS), 
and underpinned by the Ottawa Decision Support Frame-
work (ODSF), this study aims to develop and implement 
an intervention to help patients with advanced cancer 
and their clinicians make timely informed decisions 
about palliative care.
MEthods And AnAlysIs
This research protocol details the process of develop-
ment and validation of a decision aid for patients with 
advanced cancer and related doctor training for clini-
cians. The study will be conducted over 24 months, from 
November 2017 to October 2019.
Patient and public involvement
Patients were involved in setting the research question 
and in the design of the study. Patients will be asked to 
advise on interpretation of results. The results of the 
research will be disseminated to the patient community 
through patient forums.
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recruitment
Patients with advanced cancer will be recruited through 
oncology outpatient clinics and a local hospice via health 
professionals. Patients will be approached in person and 
given an information sheet. If they are interested in taking 
part, they will be contacted by a member of the research 
team and given the opportunity to ask any questions. Health 
professionals will be recruited through members of the 
research team, facilitated by clinical end-of-life care leads 
within Leeds Cancer Centre and the primary care setting. 
The member of the research team will introduce the study 
and provide them with an information sheet. Patients and 
health professionals will be recruited in the same way for both 
interviews and focus groups. All participants will be asked to 
give written consent prior to participation in the study.
Intervention development and implementation processes
The intervention development will consist of eight steps 
and the intervention implementation will consist of two 
steps, outlined (table 1) and detailed below.
1.1 ExPErt PAnEl ConsultAtIon ProCEss
Step 1.1 will be to convene an expert panel, using the 
recruitment process described above, to guide the 
development of STEP, including content format and feasi-
bility testing. They will assess the STEP intervention based 
on (1) members’ experience as patients with cancer who 
have made a decision about referral to palliative care, (2) 
healthcare professionals who are involved with patients 
in making such decisions and (3) key opinion leaders/
policy-makers who are involved in implementing health 
services for patients with advanced cancer. They will be 
independent of the research team and project steering 
committee and will engage with the research team 
through face-to-face meetings and where necessary via 
Skype and email correspondence.
1.5 Map existing patient pathways
Step 1.5 is the mapping of existing patient with advanced 
cancer clinical pathways to identify decision points and 
decision-makers within the pathway and understand 
how transition between and integration of the pathways 
currently occur. Interviews will be conducted with 16 
patients (eight prior to receiving a referral to palliative 
care, eight following a referral to palliative care) and 
eight health professionals. Participants will be recruited 
using the recruitment processes described above. Inter-
views will explore perspectives of journey from diagnosis, 
Table 1 STEP intervention development and implementation process
Step Objective Framework Method
1.1 Convene an expert panel UKMRC/IPDAS Expert consensus
(face-to-face meetings)
1.2 Needs assessment
(completed)
UKMRC/IPDAS 12 Patient and 12 clinician interviews
1.3 Review of existing resources
(completed)
UKMRC/IPDAS Literature review and
environmental scan of existing information resources
Regional survey of 20 hospitals (26 inpatient/outpatient oncology 
departments, 12 day units and 12 palliative care teams)
1.4 Evidence: collate the clinical 
evidence for treatment options
(completed)
IPDAS/UKMRC Time4PallCare Project; retrospective cohort study of
6080 cancer deaths
1.5 Map existing patients’ pathways UKMRC (1) Interviews with patients’ oncologists, oncology nurse 
specialists and general practitioners
(2) Retrospective population cohort study
2.1 Develop the prototype 
intervention and (alpha testing I)
UKMRC/IPDAS Draft–review–revise iterative process by the research team and 
design experts
2.2 Review by expert panel, focus 
groups (alpha testing II)
UKMRC/IPDAS (1) Expert panel consensus—meeting and emails
(2) Focus groups
2.3 Develop the STEP training 
module for clinicians
(1) Ottawa training module and workshop
(2) Development of STEP clinician handbook—expert consensus 
involving research team, decision support experts and medical 
educator
3.1 Implementation study (beta
testing)
IPDAS (1) Pilot STEP with patients and their clinicians
(2) Patient and clinician questionnaires
(3) Individual interviews with patients and clinicians
3.2 Implementation toolkit (1) Develop toolkit
(2) Embed toolkit within SystmOne
(3) Create STEP website
IPDAS, International Patient Decision Aids Standards; UKMRC, UK Medical Research Council.
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with particular focus on determining the potential deci-
sion points and understanding the role of the patient and 
others in the decision-making process. Health profes-
sional interviews will also explore the extent to which 
palliative care provision is being delivered by non-pallia-
tive care specialists and the rationale for this.
We will use an existing dataset containing linked data 
relating to 2479 patients with cancer from the cancer 
registry and the electronic medical record systems 
used within primary care (SystmOne) and within Leeds 
Cancer Centre (Patient Pathway Manager). From this 
linked dataset, we will map patient pathways through 
primary and secondary care from diagnosis to death. 
We will explore how the pathways differ in relation 
to patient, disease and various service level character-
istics, what treatment they received, and the number 
and nature of hospital admissions. This way will enable 
us to identify potential decision points and key deci-
sion-makers and crucially will enable us to navigate 
transitions between primary care, oncology and palli-
ative care.
2.1 develop the prototype intervention and alpha testing (I)
In step 2.1, a prototype will be developed through synthesis 
of evidence and expert consensus based on the IPDAS 
guideline and the ODSF. IPDAS will guide the process for 
synthesising the research evidence (from steps 1.2 to 1.5) 
and structuring the STEP intervention.
2.2 review by expert panel and alpha testing (II)
In step 2.2 the decision aid will be refined by patients, 
health professionals, and an expert panel. This will be 
done via four focus groups: two with patients (a mix of 
patients who have received palliative care and those who 
have not) and two with health professionals (oncologists, 
general practitioners (GPs) and oncology nurse special-
ists). Focus groups will explore the comprehensibility and 
usability of the decision aid. Data will be analysed themat-
ically and the decision aid will be iteratively modified as 
a result. The expert panel will then meet following these 
revisions and further iterations will be undertaken until 
the expert panel reach consensus regarding the content 
and format of STEP.
2.3 develop the stEP training module for clinicians
Step 2.3 consists of developing and piloting the STEP 
training module, skills-building workshop and the 
handbook. Health professionals (four GPs, four oncol-
ogists, four oncology nurse specialists) will be recruited 
to the implementation study and complete both the 
online tutorial and the skills-building workshop before 
using the intervention in clinical consultations. The 
skills-building workshop will take place within Leeds 
Cancer Centre or the GP practice during protected 
learning time and will last approximately 90 min. Feed-
back on the skills development workshop and the online 
training will be collected at the end of the workshop 
using a questionnaire.
3.1 Implementation study
In step 3.1, we will assess the acceptability and validity 
of STEP in consultations and its impact on patient care. 
Health professionals who participated in the training 
will be asked to use the STEP intervention within their 
clinical practice. Usage will be explored using interviews, 
questionnaires (Ottawa Acceptability Tool, Decision 
Support Analysis Tool and Decision Conflict Scale) and 
clinical feedback forms. They will each identify patients 
with advanced cancer who have the potential to benefit 
from palliative care but have not received a palliative care 
referral. We will aim to generate a patient population of 36 
(3 patients per health professional). If the patient agrees 
to participate, the clinician will use the STEP intervention 
in the consultation. Following the consultation, each of 
the 36 patients will be sent follow-up questionnaires and 
12 patients will also be invited to take part in a follow-up 
interview. Health professionals will be given a structured 
feedback form on which they will be asked to reflect on 
the use of the STEP intervention after each consultation 
in which it is used. They will be invited to participate in a 
semistructured interview.
3.2 Implementation toolkit
In step 3.2, an implementation toolkit will be developed 
to support the implementation of STEP in oncology 
departments and General Practice settings across the 
NHS. The toolkit will provide the necessary information 
and resources to implement the decision aid and clinical 
training and will also provide clinically feasible resources 
to evaluate its impact including The Sure Test. To support 
sustainability and continued evaluation, the toolkit will 
be embedded within the central user areas of the two 
electronic health record systems used in primary care in 
Yorkshire (EMIS and SystmOne). Any updates or modifi-
cations will be therefore be incorporated within routine 
NHS IT maintenance programmes.
We will also create a STEP website where the imple-
mentation toolkit will be available to health professionals 
who wish to adopt it within their practice. Users will be 
asked to complete a registration form so we can monitor 
where the decision aid is being used and we will request 
feedback on the implementation process within practice 
settings.
EthICs And dIssEMInAtIon
Ethical approval for the study has been granted by the 
Office for Research Ethics Committees Northern Ireland, 
approval reference 17/NI/0249. Recruitment materials, 
including information sheets and consent forms, were 
also approved. Management of participant information 
will be collected and processed in accordance with the 
Data Protection Act 1998, that is, all personal information 
will be de-identified and kept in password-protected elec-
tronic files. Information will be destroyed after 5 years.
Research dissemination and knowledge translation will 
be conducted in three ways. We will build on working 
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relationships with national bodies relevant to end-of-life 
care and broader health policy in order to shape policy 
and clinical recommendations for wider dissemination 
nationally. We will engage with palliative care experts, 
representatives from hospice networks, and palliative 
care patient and family groups to inform them of prog-
ress and emerging research findings. We will also link 
with national bodies to ensure our project is aligned with 
their priorities and channels are available for national 
dissemination of our work. We will also disseminate find-
ings via traditional academic routes of conferences and 
peer-reviewed publications.
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